Human Resources Contracts & Agreements in the Pharmaceuticals Industry
7,516 Contracts & Agreements
- Bonus & Incentive Agreements (2,392 contracts from 333 companies)
- Change of Control Agreements (235 | 61)
- Compensation Agreements (636 | 174)
- Confidentiality Agreements (19 | 13)
- Consulting Agreements (494 | 199)
- Employment Agreements (2,950 | 339)
- Non-Competition Agreements (44 | 19)
- Retention Agreements (78 | 31)
- Retirement Agreements (28 | 16)
- Separation Agreements (375 | 158)
- Severance Agreements (188 | 73)
- Transition Agreements (77 | 55)
- 4Front Ventures Corp. (6 contracts)
- 60 DEGREES PHARMACEUTICALS, INC. (8)
- Acacia Diversified Holdings, Inc. (5)
- Acasti Pharma Inc. (5)
- Accelerated Pharma, Inc. (7)
- ACELRX PHARMACEUTICALS INC (34)
- Acer Therapeutics Inc. (30)
- ACHILLION PHARMACEUTICALS INC (38)
- Aclaris Therapeutics, Inc. (46)
- Acreage Holdings, Inc. (9)
- ACURA PHARMACEUTICALS, INC (17)
- Adamis Pharmaceuticals Corp (36)
- ADIAL PHARMACEUTICALS, INC. (32)
- Aegerion Pharmaceuticals, Inc. (50)
- AEOLUS PHARMACEUTICALS, INC. (12)
- AEON Biopharma, Inc. (9)
- AERIE PHARMACEUTICALS INC (25)
- Aerpio Pharmaceuticals, Inc. (33)
- AGILE THERAPEUTICS INC (21)
- Akers Biosciences, Inc. (35)
- AKESIS PHARMACEUTICALS, INC. (3)
- Akorn (19)
- ALDER BIOPHARMACEUTICALS INC (20)
- Alexza Pharmaceuticals Inc. (10)
- ALGORX PHARMACEUTICALS INC (2)
- ALIMERA SCIENCES INC (69)
- Allergan, plc (15)
- ALSERES PHARMACEUTICALS INC (22)
- Altus Pharmaceuticals Inc. (21)
- Amag Pharmaceuticals (62)
- AmeriCann, Inc. (3)
- Amneal Pharmaceuticals, Inc. (35)
- Amphastar Pharma (12)
- Ampio Pharmaceuticals, Inc. (39)
- AMYLIN PHARMACEUTICALS INC (19)
- Amylyx Pharmaceuticals, Inc. (20)
- AN2 Therapeutics, Inc. (8)
- Anacor Pharmaceuticals, Inc. (11)
- ANADYS PHARMACEUTICALS INC (9)
- Anebulo Pharmaceuticals, Inc. (9)
- Angion Biomedica Corp. (28)
- ANGIOTECH PHARMACEUTICALS INC (11)
- ANI Pharma Inc (48)
- Anthera Pharmaceuticals Inc (23)
- Apimeds Pharmaceuticals US, Inc. (3)
- APP Pharmaceuticals, Inc. (10)
- Applied BioSciences Corp. (2)
- APRICUS BIOSCIENCES, INC. (37)
- Aquestive Therapeutics, Inc. (23)
- ARADIGM CORP (12)
- Aralez Pharmaceuticals Inc. (26)
- ARIAD PHARMACEUTICALS INC (60)
- Arog Pharmaceuticals, Inc. (1)
- ARTELO BIOSCIENCES, INC. (5)
- Artemis Therapeutics, Inc. (7)
- ARVINAS, INC. (13)
- Aspreva Pharmaceuticals CORP (5)
- Assertio Holdings, Inc. (13)
- Assertio Therapeutics, Inc (27)
- Astex Pharmaceuticals, Inc (4)
- ATAI Life Sciences B.V. (14)
- Atea Pharmaceuticals, Inc. (19)
- Athira Pharma, Inc. (34)
- Auspex Pharmaceuticals, Inc. (11)
- AUXILIUM PHARMACEUTICALS INC (68)
- AVADEL PHARMACEUTICALS PLC (21)
- AVALON PHARMACEUTICALS INC (9)
- AVANIR PHARMACEUTICALS, INC. (20)
- AVENUE THERAPEUTICS, INC. (4)
- AXIM BIOTECHNOLOGIES, INC. (1)
- Axsome Therapeutics, Inc. (9)
- AYTU BIOSCIENCE, INC (26)
- Bakhu Holdings, Corp. (13)
- BARR PHARMACEUTICALS INC (27)
- Baudax Bio, Inc. (8)
- Bausch Health Companies Inc. (53)
- BENTLEY PHARMACEUTICALS INC (8)
- Bespoke Extracts, Inc. (9)
- Big Rock Partners Acquisition Corp. (10)
- BIODELIVERY SCIENCES INTERNATIONAL INC (41)
- Biofrontera Inc. (16)
- Biohaven Ltd. (3)
- BiondVax Pharmaceuticals Ltd. (3)
- BioPharmX Corp (12)
- Biostar Pharmaceuticals, Inc. (4)
- Blue Water Acquisition Corp. (7)
- BODY & MIND INC. (7)
- Boston Therapeutics, Inc. (6)
- Braeburn Pharmaceuticals, Inc. (6)
- Bright Green Corp (8)
- Bristol-Myers Squibb (132)
- CADENCE PHARMACEUTICALS INC (16)
- CALLISTO PHARMACEUTICALS INC (7)
- Canbiola, Inc. (25)
- Cancer Prevention Pharmaceuticals, Inc. (9)
- Cannabics Pharmaceuticals Inc. (7)
- CANNAPHARMARX, INC. (3)
- Canopy Growth Corp (29)
- Cantabio Pharmaceuticals Inc. (3)
- Cara Therapeutics, Inc. (24)
- CARDAX, INC. (8)
- CASSAVA SCIENCES INC (23)
- Catalent Inc (60)
- Celator Pharmaceuticals Inc (3)
- CELGENE CORP (21)
- CERAGENIX PHARMACEUTICALS, INC. (1)
- Cerecor Inc. (31)
- Charlotte's Web Holdings, Inc. (6)
- CHIASMA, INC (20)
- CHINA PEDIATRIC PHARMACEUTICALS, INC. (4)
- CHINA PHARMA HOLDINGS, INC. (5)
- China Pharmaceuticals Inc (4)
- China QinBa Pharmaceuticals, Inc. (1)
- CinCor Pharma, Inc. (5)
- Cingulate Inc. (21)
- Citius Pharmaceuticals, Inc. (8)
- Clearside Biomedical, Inc. (26)
- Clever Leaves Holdings Inc. (13)
- CLS Holdings USA, Inc. (31)
- CNS Pharmaceuticals, Inc. (6)
- Cocrystal Pharma, Inc. (10)
- COGNITION THERAPEUTICS INC (12)
- COLLAGENEX PHARMACEUTICALS INC (8)
- COLLEGIUM PHARMACEUTICAL, INC (40)
- CoLucid Pharmaceuticals, Inc. (13)
- Columbia Care Inc. (11)
- Context Therapeutics Inc. (11)
- ContraVir Pharmaceuticals, Inc. (1)
- Corcept Therapeutics Incorporated (32)
- CorMedix Inc. (34)
- COSMO VENTURES INC (2)
- CPEX Pharmaceuticals, Inc. (5)
- Cronos Group Inc. (21)
- CUBIST PHARMACEUTICALS INC (33)
- CUMBERLAND PHARMACEUTICALS INC (62)
- Cure Pharmaceutical Holding Corp. (13)
- CymaBay Therapeutics, Inc. (11)
- Cyteir Therapeutics, Inc. (12)
- Dermata Therapeutics, Inc. (20)
- DiCE MOLECULES HOLDINGS, LLC (3)
- Dova Pharmaceuticals Inc. (15)
- DURECT CORP (3)
- DUSA PHARMACEUTICALS INC (29)
- EASTON PHARMACEUTICALS INC. (1)
- Edgewise Therapeutics, Inc. (8)
- Egalet Corp (33)
- Elanco Animal Health Inc (14)
- Eleison Pharmaceuticals Inc (8)
- ELITE PHARMACEUTICALS INC (14)
- Elixir Pharmaceuticals, Inc. (9)
- Eloxx Pharmaceuticals, Inc. (32)
- ENCYSIVE PHARMACEUTICALS INC (8)
- Endexx Corp (1)
- Endo International plc (81)
- Endo Pharmaceuticals Solutions Inc. (16)
- EPHS HOLDINGS, INC. (1)
- EPIX Pharmaceuticals, Inc. (22)
- Eton Pharmaceuticals, Inc. (7)
- Evofem Biosciences, Inc. (39)
- Evoke Pharma Inc (23)
- Evolus, Inc. (23)
- Exactus, Inc. (24)
- EYEGATE PHARMACEUTICALS INC (18)
- EYENOVIA, INC. (27)
- EyePoint Pharmaceuticals, Inc. (41)
- EYETECH PHARMACEUTICALS INC (18)
- FERMAVIR PHARMACEUTICALS, INC. (1)
- Foamix Pharmaceuticals Ltd. (7)
- Fresenius Kabi Pharmaceuticals Holding, Inc. (6)
- FRONTIER OILFIELD SERVICES INC (9)
- Fulcrum Therapeutics, Inc. (34)
- Furiex Pharmaceuticals, Inc. (3)
- Gala Pharmaceutical Inc. (1)
- GB SCIENCES INC (15)
- GENAISSANCE PHARMACEUTICALS INC (2)
- GRAYBUG VISION, INC. (9)
- GREEN HYGIENICS HOLDINGS INC. (6)
- Green Thumb Industries Inc. (3)
- GridIron BioNutrients, Inc. (3)
- GUILFORD PHARMACEUTICALS INC (9)
- GW PHARMACEUTICALS PLC (10)
- Harmony Biosciences Holdings, Inc. (13)
- HARROW HEALTH, INC. (35)
- HARVEST HEALTH & RECREATION INC. (1)
- Haymaker Acquisition Corp. III (10)
- Horizon Pharma plc (67)
- Hoth Therapeutics, Inc. (16)
- iANTHUS CAPITAL HOLDINGS, INC. (7)
- IDENIX PHARMACEUTICALS INC (19)
- Ikena Oncology, Inc. (7)
- IMAGING3 INC (1)
- IMARA Inc. (39)
- IMMTECH PHARMACEUTICALS, INC. (1)
- INNOVATE BIOPHARMACEUTICALS, INC. (44)
- Innoviva, Inc. (48)
- Innovive Pharmaceuticals, Inc. (2)
- INSPIRE PHARMACEUTICALS INC (31)
- IntelGenx Technologies Corp. (12)
- Intersect ENT, Inc. (16)
- Intra-Cellular Therapies, Inc. (55)
- ISTA PHARMACEUTICALS INC (5)
- Item 9 Labs Corp. (1)
- Iterum Therapeutics plc (25)
- Jaguar Health, Inc. (10)
- JAVELIN PHARMACEUTICALS, INC (7)
- Jazz Pharmaceuticals plc (118)
- Jiangbo Pharmaceuticals, Inc. (2)
- Johnson & Johnson (24)
- Journey Medical Corp (4)
- JUNIPER PHARMACEUTICALS INC (30)
- Jushi Holdings Inc. (17)
- Kala Pharmaceuticals, Inc. (12)
- Kaleido Biosciences, Inc. (11)
- Kannalife Inc (7)
- Kaya Holdings, Inc. (2)
- KEMPHARM, INC (35)
- KING PHARMACEUTICALS INC (33)
- KOLLTAN PHARMACEUTICALS INC (3)
- KOS PHARMACEUTICALS INC (7)
- Landos Biopharma, Inc. (9)
- Lannett Company, Inc. (40)
- Lev Pharmaceuticals Inc (4)
- Level Brands, Inc. (18)
- Lexaria Bioscience Corp. (20)
- Lilly (Eli) & Co. (38)
- LIPELLA PHARMACEUTICALS INC (12)
- Lipocine Inc. (15)
- Liquidia Corp (20)
- Liquidia Technologies Inc (8)
- Longboard Pharmaceuticals, Inc. (13)
- Lowell Farms Inc. (2)
- Luckwel Pharmaceuticals Inc. (6)
- Lumena Pharmaceuticals, Inc. (2)
- Lyra Therapeutics, Inc. (18)
- Mallinckrodt (76)
- MAP Pharmaceuticals, Inc. (10)
- Marijuana Co of America, Inc. (4)
- MARINUS PHARMACEUTICALS INC (36)
- MAXIM PHARMACEUTICALS INC (9)
- Medicine Man Technologies, Inc. (27)
- MedMen Enterprises, Inc. (5)
- Melt Pharmaceuticals, Inc. (5)
- MEMORY PHARMACEUTICALS CORP (9)
- Menlo Therapeutics Inc. (18)
- Merck (113)
- MICROCHANNEL TECHNOLOGIES CORP (6)
- MiddleBrook Pharmaceuticals, Inc. (13)
- Milestone Pharmaceuticals Inc. (22)
- MILLENNIUM PHARMACEUTICALS INC (4)
- Mind Medicine (MindMed) Inc. (10)
- MIRA PHARMACEUTICALS, INC. (11)
- MJ Holdings, Inc. (18)
- Molecular Insight Pharmaceuticals, Inc. (18)
- Mylan N.V. (40)
- MYnd Analytics, Inc. (10)
- MyoKardia Inc (19)
- Nabriva Therapeutics plc (39)
- NEKTAR THERAPEUTICS (57)
- Neos Therapeutics, Inc. (21)
- Neuralstem, Inc. (29)
- NEW RIVER PHARMACEUTICALS INC (3)
- NewBridge Global Ventures, Inc. (18)
- NEXIEN BIOPHARMA, INC. (3)
- NGM BIOPHARMACEUTICALS INC (15)
- Notis Global, Inc. (10)
- NovaBay Pharmaceuticals, Inc. (50)
- Novan, Inc. (35)
- NOVEN PHARMACEUTICALS INC (5)
- NPS PHARMACEUTICALS INC (28)
- NUCRYST Pharmaceuticals Corp. (12)
- NURX PHARMACEUTICALS, INC. (2)
- OCULAR THERAPEUTIX, INC (51)
- OMEROS CORP (9)
- Omthera Pharmaceuticals, Inc. (6)
- OncoMed Pharmaceuticals Inc (14)
- Onconova Therapeutics, Inc. (19)
- One World Pharma, Inc. (6)
- ONYX PHARMACEUTICALS INC (17)
- OPIANT PHARMACEUTICALS, INC. (17)
- OPTIMER PHARMACEUTICALS INC (7)
- OptiNose, Inc. (35)
- ORAMED PHARMACEUTICALS INC. (45)
- Organon & Co. (12)
- OSCIENT PHARMACEUTICALS CORP (5)
- OSI PHARMACEUTICALS INC (27)
- Osmotica Pharmaceuticals plc (14)
- OTONOMY, INC. (16)
- Pacira Pharmaceuticals, Inc. (56)
- Panacea Acquisition Corp (9)
- PANACOS PHARMACEUTICALS, INC. (11)
- Paratek Pharmaceuticals, Inc. (66)
- PaxMedica, Inc. (10)
- PEAK PHARMACEUTICALS, INC. (3)
- PENWEST PHARMACEUTICALS CO (16)
- Perrigo (79)
- PetLife Pharmaceuticals, Inc. (4)
- Petros Pharmaceuticals, Inc. (6)
- Pfizer (45)
- Pharmagreen Biotech Inc. (1)
- PHARMOS CORP (6)
- Phathom Pharmaceuticals, Inc. (25)
- Phibro Animal Health Corporation (15)
- Phoenix Life Sciences International Limited. (1)
- Pivot Pharmaceuticals Inc. (8)
- Planet 13 Holdings Inc. (1)
- PLAYERS NETWORK (2)
- PLIANT THERAPEUTICS, INC. (9)
- PLx Pharma Inc. (34)
- PONIARD PHARMACEUTICALS, INC. (65)
- PRAECIS PHARMACEUTICALS INC (2)
- PREDIX PHARMACEUTICALS HOLDINGS INC (4)
- Prestige Brands Holdings Inc (17)
- PRESTWICK PHARMACEUTICALS INC (2)
- Processa Pharmaceuticals, Inc. (8)
- Profile Solutions, Inc. (5)
- ProPhase Labs, Inc. (21)
- PROTEO INC (2)
- PROVECTUS BIOPHARMACEUTICALS, INC. (24)
- Provention Bio, Inc. (22)
- Pulmatrix, Inc. (25)
- QUANTA INC (7)
- QUARK PHARMACEUTICALS INC (12)
- QUATRX PHARMACEUTICALS CO (1)
- QUESTCOR PHARMACEUTICALS INC (7)
- Ra Pharmaceuticals, Inc. (4)
- RADIENT PHARMACEUTICALS Corp (12)
- Rain Therapeutics Inc. (13)
- Rani Therapeutics Holdings, Inc. (12)
- REATA PHARMACEUTICALS INC (19)
- Recro Pharma, Inc. (25)
- Reliant Pharmaceuticals, Inc. (10)
- RELMADA THERAPEUTICS, INC. (25)
- RespireRx Pharmaceuticals Inc. (44)
- resTORbio, Inc. (38)
- Revance Therapeutics, Inc. (57)
- Rib-X Pharmaceuticals, Inc. (19)
- ROCK CREEK PHARMACEUTICALS, INC. (19)
- Roivant Sciences Ltd. (16)
- Royalty Pharma plc (2)
- Sagent Pharmaceuticals, Inc. (20)
- SALIX PHARMACEUTICALS LTD (8)
- SANCILIO PHARMACEUTICALS COMPANY, INC. (4)
- Satsuma Pharmaceuticals, Inc. (10)
- SAVIENT PHARMACEUTICALS INC (35)
- SCICLONE PHARMACEUTICALS INC (50)
- Scopus BioPharma Inc. (3)
- scPharmaceuticals Inc. (10)
- SCYNEXIS INC (21)
- SenesTech, Inc. (15)
- Shuttle Pharmaceuticals, Inc. (1)
- Sienna Biopharmaceuticals, Inc. (30)
- SIGA TECHNOLOGIES INC (31)
- Sirtris Pharmaceuticals, Inc. (4)
- Somanta Pharmaceuticals Inc. (1)
- Sonoma Pharmaceuticals, Inc. (32)
- Strongbridge Biopharma plc (7)
- Sucampo Pharmaceuticals, Inc. (28)
- SUNWIN STEVIA INTERNATIONAL, INC. (6)
- Supernus Pharmaceuticals, Inc. (27)
- SYNERGY PHARMACEUTICALS, INC. (27)
- TAPESTRY PHARMACEUTICALS, INC (6)
- Target Group Inc. (1)
- Targeted Medical Pharma, Inc. (20)
- Tarsus Pharmaceuticals, Inc. (4)
- TAURIGA SCIENCES, INC. (6)
- Telomir Pharmaceuticals, Inc. (7)
- Tenzing Acquisition Corp. (9)
- Terns Pharmaceuticals, Inc. (29)
- Terra Tech Corp. (28)
- TerrAscend Corp. (4)
- TETRALOGIC PHARMACEUTICALS CORP (15)
- TETRAPHASE PHARMACEUTICALS INC (9)
- TEVA PHARMACEUTICAL INDUSTRIES LTD (50)
- Textmunication Holdings, Inc. (5)
- TFF Pharmaceuticals, Inc. (11)
- THAR PHARMACEUTICALS INC (2)
- The Medicines Company (35)
- TherapeuticsMD, Inc. (22)
- Theravance Biopharma, Inc. (16)
- Theseus Pharmaceuticals, Inc. (8)
- TIBET PHARMACEUTICALS, INC. (5)
- Tilray, Inc. (25)
- TILT Holdings Inc. (13)
- TITAN PHARMACEUTICALS INC (29)
- Trevi Therapeutics, Inc. (11)
- Tribute Pharmaceuticals Canada Inc. (11)
- Tricida, Inc. (7)
- Trubion Pharmaceuticals, Inc (6)
- Trulieve Cannabis Corp. (17)
- Upjohn Inc (24)
- Urigen Pharmaceuticals, Inc. (8)
- Urovant Sciences Ltd. (15)
- VALEANT PHARMACEUTICALS INTERNATIONAL (8)
- Valera Pharmaceuticals Inc (5)
- Vallon Pharmaceuticals, Inc. (21)
- Ventyx Biosciences, Inc. (13)
- Verano Holdings Corp. (5)
- Verona Pharma plc (2)
- Verrica Pharmaceuticals Inc. (22)
- VIA Pharmaceuticals, Inc. (15)
- Viamet Pharmaceuticals Holdings LLC (4)
- VICURON PHARMACEUTICALS INC (2)
- VION PHARMACEUTICALS INC (7)
- VioQuest Pharmaceuticals, Inc. (4)
- Vireo Health International, Inc. (27)
- Virpax Pharmaceuticals, Inc. (23)
- Vitae Pharmaceuticals, Inc (10)
- Vitality Biopharma, Inc. (12)
- VIVUS INC (16)
- Vyrix Pharmaceuticals, Inc. (3)
- Wave Life Sciences Ltd. (33)
- WEED, INC. (7)
- Winston Pharmaceuticals, Inc. (1)
- XANODYNE PHARMACEUTICALS INC (12)
- Xeris Biopharma Holdings, Inc. (6)
- XERIS PHARMACEUTICALS INC (15)
- Zoetis (17)
- ZOGENIX, INC. (34)
- Zomedica Pharmaceuticals Corp. (33)
- Zynerba Pharmaceuticals, Inc. (33)
- Employment Agreement, effective as of November 26, 2024, between Canopy Growth Corporation and Luc Mongeau (Canopy Growth Corp, Filed With SEC on November 26, 2024)
- Executive Employment Agreement dated October 1, 2024 with Michael Shankman (Lexaria Bioscience Corp., Filed With SEC on November 26, 2024)
- Executive Employment Agreement dated August 31, 2024 with Richard Christopher (Lexaria Bioscience Corp., Filed With SEC on November 26, 2024)
- First Amendment to the TNF Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Akers Biosciences, Inc., Filed With SEC on November 26, 2024)
- Form of Independent Contractor Agreement, dated November 19, 2024, by and between Virpax Pharmaceuticals, Inc. and Jat Consulting Corp., the personal corporation of Mr. Jatinder... (Virpax Pharmaceuticals, Inc., Filed With SEC on November 22, 2024)
- Employment Agreement between Michael Abrams and NRx Pharmaceuticals, Inc., dated November 18, 2024 (Big Rock Partners Acquisition Corp., Filed With SEC on November 20, 2024)
- Form of Independent Contractor Agreement, dated November 18, 2024, by and between Virpax Pharmaceuticals, Inc. and Chaudhry U Consulting Inc (Virpax Pharmaceuticals, Inc., Filed With SEC on November 20, 2024)
- Consulting Agreement dated as of August 26, 2024 between Can B Corp. and Magna Global Ventures, LLC (Canbiola, Inc., Filed With SEC on November 19, 2024)
- Consulting Agreement dated as of July 29, 2024 between Nascent Pharma, LLC and Vivid Integrated Solutions, LLC (Canbiola, Inc., Filed With SEC on November 19, 2024)
- Employment Agreement, dated as of November 18, 2024, by and between the Company and Hugh Davis (Aclaris Therapeutics, Inc., Filed With SEC on November 18, 2024)
- Second Amended and Restated Employment Agreement, dated as of November 12, 2024 by and between the Company and Hermann Luebbert (Biofrontera Inc., Filed With SEC on November 14, 2024)
- Consulting Agreement dated August 9, 2024 between Iterum Therapeutics International Limited and Dr. Michael W. Dunne (Iterum Therapeutics plc, Filed With SEC on November 14, 2024)
- Amended Employment Agreement, by and between the Registrant and Saundra Pelletier, dated as of November 8, 2024 (Evofem Biosciences, Inc., Filed With SEC on November 14, 2024)
- Amended Employment Agreement, by and between the Registrant and Ivy Zhang, dated as of November 8, 2024 (Evofem Biosciences, Inc., Filed With SEC on November 14, 2024)
- Employment Agreement, by and between the Registrant and Todd Anderman, dated as of October 4, 2024 (OCULAR THERAPEUTIX, INC, Filed With SEC on November 14, 2024)
- Amendment No. 1 to the Employment Agreement, by and between the Registrant and Dr. Peter Kaiser, dated as of March 28, 2024 (OCULAR THERAPEUTIX, INC, Filed With SEC on November 14, 2024)
- Employment Agreement, by and between the Registrant and Dr. Peter Kaiser, dated as of February 21, 2024 (OCULAR THERAPEUTIX, INC, Filed With SEC on November 14, 2024)
- Employment Agreement, by and between the Registrant and Dr. Jeffrey Heier, dated as of February 21, 2024 (OCULAR THERAPEUTIX, INC, Filed With SEC on November 14, 2024)
- Amended and Restated Employment Agreement by and between Aytu BioPharma, Inc. and Ryan J. Selhorn dated November 11, 2024 (AYTU BIOSCIENCE, INC, Filed With SEC on November 13, 2024)
- Amendment No. 2 to 2022 Employment Inducement Award Plan (Terns Pharmaceuticals, Inc., Filed With SEC on November 12, 2024)
- Transition Agreement between Terns, Inc. and Mark Vignola dated July 23, 2024 (Terns Pharmaceuticals, Inc., Filed With SEC on November 12, 2024)
- Separation Agreement between Terns, Inc. and Bryan Yoon dated July 23, 2024 (Terns Pharmaceuticals, Inc., Filed With SEC on November 12, 2024)
- Non-Employee Director Compensation Policy, effective as of August 6, 2024 (Wave Life Sciences Ltd., Filed With SEC on November 12, 2024)
- Axsome Therapeutics, Inc. Form of Restricted Stock Unit Agreement (Executives and Non-Employee Directors) pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation... (Axsome Therapeutics, Inc., Filed With SEC on November 12, 2024)
- Axsome Therapeutics, Inc. Form of Restricted Stock Unit Agreement (Non-Executives) pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation Plan (Axsome Therapeutics, Inc., Filed With SEC on November 12, 2024)
- Axsome Therapeutics, Inc. Form of Stock Option Agreement pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation Plan (Axsome Therapeutics, Inc., Filed With SEC on November 12, 2024)
- Amendment No. 6 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan (ADIAL PHARMACEUTICALS, INC., Filed With SEC on November 12, 2024)
- Non-Employee Director Compensation Policy, as amended July 11, 2024 (Milestone Pharmaceuticals Inc., Filed With SEC on November 12, 2024)
- CFO Consulting Agreement, by and between Apimeds Pharmaceuticals US, Inc. and Mark Corrao, dated October 4, 2024 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on November 8, 2024)
- AMENDMENT NO. 3 TO THE GREEN THUMB INDUSTRIES INC. 2018 STOCK AND INCENTIVE PLAN (Green Thumb Industries Inc., Filed With SEC on November 8, 2024)
- ANI Pharmaceuticals, Inc Amended and Restated 2022 Stock Incentive Plan Notice of Restric (ANI Pharma Inc, Filed With SEC on November 8, 2024)
- ANI Pharmaceuticals, Inc. Amended and Restated 2022 Stock Incentive Plan Sub-Plan for U.K. Employees (ANI Pharma Inc, Filed With SEC on November 8, 2024)
- Amendment No. 2 to Employment Agreement, dated as of November 5, 2024, by and among the Company, JMGT, LLC and Louis Jon Barack (Jushi Holdings Inc., Filed With SEC on November 7, 2024)
- Consulting Agreement by and between the Registrant and Christopher Krueger, dated April 5, 2024, as amended by Amendment No. 1 to Consulting Agreement, dated September 10, 2024 (Ventyx Biosciences, Inc., Filed With SEC on November 7, 2024)
- Separation and Release Agreement, dated August 30, 2024, by and between the Registrant and Martin Auster (Ventyx Biosciences, Inc., Filed With SEC on November 7, 2024)
- Non-Employee Director Compensation Policy, Amended June 6, 2024 with an effective date of July 1, 2024 (Cerecor Inc., Filed With SEC on November 7, 2024)
- Amended and Restated Employment Agreement, effective as of August 8, 2024, by and between the Company and Marilyn Carlson, M.D (Evoke Pharma Inc, Filed With SEC on November 7, 2024)
- Amended and Restated Employment Agreement, effective as of August 8, 2024, by and between the Company and Mark Kowieski (Evoke Pharma Inc, Filed With SEC on November 7, 2024)
- Second Amended and Restated Employment Agreement, effective as of August 8, 2024, by and between the Company and Matthew D'Onofrio (Evoke Pharma Inc, Filed With SEC on November 7, 2024)
- Amendment #1, dated September 1, 2022, to the Consulting Agreement, dated October 19, 2020, between SIGA Technologies, Inc. and Tides Group, LLC (SIGA TECHNOLOGIES INC, Filed With SEC on November 7, 2024)